trusted seller
Gemtaz 1.2 G Injection Gemtaz 1.2 G Injection
Gemtaz 1.2 G Injection
Gemtaz 1.2 G Injection

Gemtaz 1.2 G Injection

उत्पाद विवरण:

  • नमक की संरचना Gemcitabine Hydrochloride 1.2 g
  • उत्पत्ति INDIA
  • संकेत Used for the treatment of various cancers including non-small cell lung cancer, pancreatic cancer, bladder cancer, and breast cancer
  • खुराक प्रपत्र Lyophilized Powder for Injection
  • फ़ीचर
  • एप्लीकेशन
  • स्टोरेज निर्देश Store below 25 C, protect from light
  • अधिक देखने के लिए क्लिक करें
X

मूल्य और मात्रा

  • 1
  • Single vial containing 1.2 g powder for reconstitution
  • Antineoplastic agent
  • Prescription only
  • Contraindicated in patients with hypersensitivity to Gemcitabine
  • Myelosuppression, nausea, vomiting, rash, fever, liver enzyme elevations
  • Intravenous infusion after reconstitution
  • Approved by Indian regulatory authorities
  • C9H11F2N3O4·HCl
  • Reconstitute with sterile water for injection as per prescribing information
  • Use with caution in hepatic or renal impairment

उत्पाद की विशेषताएं

  • Used for the treatment of various cancers including non-small cell lung cancer, pancreatic cancer, bladder cancer, and breast cancer
  • Lyophilized Powder for Injection
  • महीने
  • Store below 25 C, protect from light
  • Gemcitabine Hydrochloride 1.2 g
  • INDIA
  • Single vial containing 1.2 g powder for reconstitution
  • Antineoplastic agent
  • Prescription only
  • Contraindicated in patients with hypersensitivity to Gemcitabine
  • Myelosuppression, nausea, vomiting, rash, fever, liver enzyme elevations
  • Intravenous infusion after reconstitution
  • Approved by Indian regulatory authorities
  • C9H11F2N3O4·HCl
  • Reconstitute with sterile water for injection as per prescribing information
  • Use with caution in hepatic or renal impairment

व्यापार सूचना

  • प्रति महीने
  • दिन

उत्पाद वर्णन

Gemtaz Infusmart 1.2g Injection is used in the treatment of non-small cell lung cancer, breast cancer, pancreatic cancer, urinary bladder cancer, and ovarian cancer.

Gemtaz Infusmart 1.2g Injection is given as an injection by a qualified medical professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

The most common side effects of this medicine include nausea, vomiting, loss of appetite, hair loss and low blood platelets. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with heart, liver, and blood uric acid levels.

Before taking it, tell your doctor if you have heart disease, liver, or kidney problems or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your doctor know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.



Effective Chemotherapy for Multiple Cancers

Gemtaz 1.2 G Injection plays a pivotal role in the treatment of various cancers, including non-small cell lung, pancreatic, bladder, and breast cancers. Its efficacy is rooted in Gemcitabine Hydrochloride, offering patients a powerful option within modern oncology. As a prescription antineoplastic agent, its use is guided by trained clinicians to maximize therapeutic outcomes while maintaining safety.


Safe and Sterile Administration

Each Gemtaz vial contains 1.2 g of lyophilized powder, intended for single use after reconstitution with sterile water for injection. The preparation and administration must be performed under aseptic conditions by healthcare professionals, following detailed prescribing instructions. Proper storage and handling maintain its efficacy and safety throughout its 24-month shelf life.


Storage and Handling Guidelines

Gemtaz should be stored below 25C and protected from light to maintain its stability. The product has a shelf life of 24 months and must be kept out of reach of unauthorized personnel. Ensuring appropriate storage conditions helps preserve the sterility and effectiveness of the medication until use.

FAQ's of Gemtaz 1.2 G Injection:


Q: How is Gemtaz 1.2 G Injection prepared and administered?

A: Gemtaz should be reconstituted using sterile water for injection according to the prescribing instructions and administered as an intravenous infusion by qualified healthcare professionals.

Q: What medical conditions is Gemtaz 1.2 G Injection used to treat?

A: This injection is indicated for the treatment of several cancers, including non-small cell lung cancer, pancreatic cancer, bladder cancer, and breast cancer.

Q: When should Gemtaz not be used?

A: Gemtaz is contraindicated in patients with known hypersensitivity to Gemcitabine. It should also be used cautiously in individuals with hepatic or renal impairment.

Q: Where should Gemtaz 1.2 G Injection be stored before use?

A: It should be stored below 25C, protected from light, and kept in a secure location until it is ready for reconstitution and administration.

Q: What are the possible side effects associated with Gemtaz 1.2 G Injection?

A: Potential side effects include myelosuppression, nausea, vomiting, rash, fever, and elevated liver enzymes. Patients should be closely monitored during therapy.

Q: What benefits does Gemtaz offer to cancer patients?

A: Gemtaz provides a clinically approved, effective chemotherapeutic option for several types of cancer, helping to slow disease progression and improve patient outcomes when used as directed.

Q: What is the process for using Gemtaz 1.2 G Injection in clinical settings?

A: The process involves reconstituting the lyophilized powder with sterile water, ensuring the solution is clear before administering it intravenously, and adhering strictly to recommended dosing protocols.

Tell us about your requirement
product

Price:  

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
मोबाइल number

Email

एंटी कैंसर इंजेक्शन अन्य उत्पाद



Back to top